EMY says the FDA has added a new warning covering weight loss drugs such as Wegovy. The listing gives no detail on what the warning says, so tap through.
Recap by typeshit. Full story at EMY.
NSW peptide hospitalisations went from five in July 2025 to over 200 in September 2026, and needle programs say syringe machines are emptying within hours.
Bikman says midface volume drops about 7% for every 10 kg lost, and that bariatric surgery patients see the same change.
A woman with bipolar disorder developed tremor and slurred speech three weeks into Zepbound. An outside expert advises checking lithium levels early, not avoiding the drugs.
8:51
Regan Archibald takes on a common question from people using retatrutide: whether the tiredness some report wears off.
SIA LearnBetter rates each claimed use from Proven to Failed and lists legal status in ten regions, in six languages. It says entries haven't yet been reviewed by a clinician.
The review argues that a patient's own risk profile matters more than broad safety worries when looking at GLP-1 receptor agonists.
Loading…